Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 12p70 is an essential pro-inflammatory cytokine that orchestrates both innate and adaptive immune responses by promoting type I cellular immunity through its effects on NK cells and helper/cytotoxic lymphocytes. Its unique structure—a heterodimer composed of distinct genetic products—enables precise regulation but also links it functionally to other members of its cytokine family. Because dysregulated signaling can contribute to pathology while appropriate activation enhances host defense mechanisms against infection or malignancy, it remains an important focus for research into new immunotherapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 12p70 (IL-12p70).